As an observational study, there are likely sources of bias associated with anti-IL-23 treatment that were not captured or adjusted for in our analysis such as time-varying factors or a higher incidence of diabetes among non-anti-IL-23 patients. Here, IL23A is linked to diabetes mellitus.